Rachel Diamant is the founder of Emendo Biotherapeutics. Emendo Biotherapeutics has raised $73M in total funding. Latest round: Series B.
Rachel Diamant is a co-founder of Emendo Biotherapeutics, a New York-based gene therapy company. Founded in 2015, Emendo Biotherapeutics focuses on utilizing protein engineering for precision gene editing to treat various genetic disorders and diseases by altering single alleles. The company has raised a total of $73 million in funding.
Full founder directory · Investor directory · Company funding database · Fundraising library